Genomic Confirmation of Borrelia garinii in South Carolina, USA
Concetti Chiave
Borrelia garinii isolated in South Carolina differs from Canadian strains.
Sintesi
Abstract:
- Lyme disease caused by Borrelia burgdorferi sensu lato.
- B. garinii causes Lyme disease in Eurasia.
- Isolation and sequencing of B. garinii from a cotton mouse in South Carolina.
- Phylogenetic analysis shows no association with Canadian isolates.
Introduction:
- Lyme disease caused by B. burgdorferi sensu lato species complex.
- B. burgdorferi sensu stricto, B. garinii, and B. afzelii are main causes.
- B. garinii found in islands off Newfoundland and Labrador, Canada.
- Isolation and genome sequencing of South Carolina B. garinii isolate.
- Second B. garinii isolate from the same repository.
- Phylogenetic analysis links strains to Europe, not Canada.
Traduci origine
In un'altra lingua
Genera mappa mentale
dal contenuto originale
Visita l'originale
www.medscape.com
Genomic Confirmation of Borrelia garinii, United States
Statistiche
"B. garinii isolate from a cotton mouse in South Carolina, USA."
"Phylogenetic analysis does not associate these isolates with the previously described isolates of B. garinii from Canada."
"B. garinii isolate from a repository of strains from rodent hosts and tick vectors in the southeastern United States."
"Phylogenetic analysis showed that these 2 strains from the southeastern United States were most closely related to a group of B. garinii isolates from Europe."
Citazioni
"Lyme disease is a multisystem disorder primarily caused by Borrelia burgdorferi sensu lato."
"B. garinii has been identified on islands off the coast of Newfoundland and Labrador, Canada."
"Phylogenetic analysis showed that these 2 strains from the southeastern United States were most closely related to a group of B. garinii isolates from Europe."
Domande più approfondite
How does the presence of B. garinii in the USA impact Lyme disease research globally?
The presence of B. garinii in the USA expands the understanding of the global distribution and genetic diversity of Borrelia species causing Lyme disease. This discovery challenges the previous notion that B. garinii was limited to Eurasia and Canada, highlighting the need for further research into the ecology, transmission dynamics, and pathogenicity of this species in North America. The identification of B. garinii in the USA also underscores the importance of surveillance and monitoring efforts to track the emergence and spread of different Borrelia species, which can ultimately inform public health strategies and interventions on a global scale.
What factors may contribute to the differences between B. garinii strains in Europe and North America?
Several factors may contribute to the differences observed between B. garinii strains in Europe and North America. Firstly, geographical isolation and ecological differences between the two regions could lead to distinct evolutionary pathways and genetic variations in Borrelia populations. Host preferences and reservoir species may also differ between Europe and North America, influencing the transmission dynamics and adaptation of B. garinii strains in each region. Additionally, human activities such as travel and trade can facilitate the movement of infected hosts and vectors across continents, potentially leading to the introduction of novel Borrelia strains to new geographic areas. These factors collectively contribute to the genetic diversity and divergence of B. garinii strains between Europe and North America.
How can genomic sequencing of Borrelia species aid in understanding disease transmission patterns?
Genomic sequencing of Borrelia species plays a crucial role in elucidating disease transmission patterns by providing insights into the genetic diversity, population structure, and evolutionary relationships of different strains. By comparing whole-genome sequences of Borrelia isolates from various geographic locations, researchers can identify genetic markers associated with virulence, host adaptation, and antibiotic resistance, which are essential for understanding the pathogenicity and epidemiology of Lyme disease. Furthermore, genomic data can help trace the origins of Borrelia strains, track their spread across different hosts and environments, and uncover potential reservoir species involved in disease transmission cycles. Ultimately, genomic sequencing enables researchers to map out the intricate networks of Borrelia transmission, informing public health strategies and interventions to mitigate the impact of Lyme disease.